Browse verified doctors or let our care team help you find the doctor best suited to your condition, treatment goals, and budget.
Delhi, India
Choosing BLK-Max Super Speciality Hospital for Immunotherapy gives patients access to specialist-led cancer treatment, advanced diagnostic services, and coordinated follow-up care. Established in 1959, the JCI, NABH accredited hospital is located in Delhi, India and operates 650 beds with modern oncology infrastructure.
Immunotherapy works differently from conventional treatments that directly destroy rapidly dividing cancer cells. It helps the immune system identify, recognize, or respond more effectively to cancer cells. The treatment approach varies according to the patient's cancer and may involve checkpoint inhibitors, antibody-based medicines, or other immunotherapeutic agents. Doctors monitor patients throughout treatment to evaluate effectiveness and identify adverse reactions early.
Artemis Health Institute provides dedicated Immunotherapy services with an emphasis on evidence-based cancer treatment, individualized therapy selection, and ongoing safety assessment. Established in 2007, the JCI, NABH accredited hospital is based in Gurgaon, India and has 750 beds supported by modern medical oncology facilities.
Immunotherapy can be used to support the body's natural immune response against certain cancers. Before starting therapy, specialists may review pathology reports, imaging results, biomarkers, previous treatments, and the patient's general health. Depending on the clinical situation, immunotherapy may be administered intravenously or through other approved routes and may be given for a defined number of cycles or until disease progression or unacceptable toxicity occurs. Follow-up assessments help determine treatment response and manage potential side effects.
Medanta - The Medicity provides specialized Immunotherapy with a focus on personalized cancer care, appropriate treatment selection, and close monitoring during therapy. Established in 2009, the JCI, NABH accredited hospital is located in Gurgaon, India and operates 1250 beds with advanced oncology and infusion-care facilities.
Immunotherapy uses medicines that help the body's immune system recognize and attack cancer cells more effectively. Depending on the cancer type and its characteristics, treatment may include immune checkpoint inhibitors, monoclonal antibodies, or other immune-based therapies. Before treatment, doctors may evaluate the cancer type, stage, biomarkers, and overall health to determine whether immunotherapy is appropriate. Patients are monitored regularly for treatment response and possible immune-related side effects.
Gleneagles Hospital Mumbai provides dedicated Immunotherapy services with an emphasis on evidence-based cancer treatment, individualized therapy selection, and ongoing safety assessment. Established in 1996, the JCI accredited hospital is based in Mumbai, India and has 450 beds supported by modern medical oncology facilities.
Immunotherapy can be used to support the body's natural immune response against certain cancers. Before starting therapy, specialists may review pathology reports, imaging results, biomarkers, previous treatments, and the patient's general health. Depending on the clinical situation, immunotherapy may be administered intravenously or through other approved routes and may be given for a defined number of cycles or until disease progression or unacceptable toxicity occurs. Follow-up assessments help determine treatment response and manage potential side effects.
Ghaziabad, India
Max Super Specialty Hospital, Vaishali provides specialized Immunotherapy with a focus on personalized cancer care, appropriate treatment selection, and close monitoring during therapy. Established in 2008, the NABL, NABH accredited hospital is located in Ghaziabad, India and operates 370 beds with advanced oncology and infusion-care facilities.
Immunotherapy uses medicines that help the body's immune system recognize and attack cancer cells more effectively. Depending on the cancer type and its characteristics, treatment may include immune checkpoint inhibitors, monoclonal antibodies, or other immune-based therapies. Before treatment, doctors may evaluate the cancer type, stage, biomarkers, and overall health to determine whether immunotherapy is appropriate. Patients are monitored regularly for treatment response and possible immune-related side effects.
Max Hospital, Gurgaon provides dedicated Immunotherapy services with an emphasis on evidence-based cancer treatment, individualized therapy selection, and ongoing safety assessment. Established in 2007, the ISO, NABH, NABL accredited hospital is based in Gurgaon, India and has 104 beds supported by modern medical oncology facilities.
Immunotherapy can be used to support the body's natural immune response against certain cancers. Before starting therapy, specialists may review pathology reports, imaging results, biomarkers, previous treatments, and the patient's general health. Depending on the clinical situation, immunotherapy may be administered intravenously or through other approved routes and may be given for a defined number of cycles or until disease progression or unacceptable toxicity occurs. Follow-up assessments help determine treatment response and manage potential side effects.
Indraprastha Apollo Hospital offers specialized Immunotherapy supported by experienced oncology specialists, advanced treatment technology, and structured patient monitoring. Established in 1996, the JCI accredited hospital is situated in Delhi, India and has 710 beds with comprehensive cancer treatment infrastructure.
Immunotherapy may be recommended for selected patients when the cancer has specific characteristics that make it responsive to immune-based treatment. Certain medicines work by removing inhibitory signals that prevent immune cells from attacking cancer, while others target specific immune pathways or cancer-associated proteins. Treatment is usually administered according to a planned schedule, with patients monitored for fatigue, skin reactions, inflammation, and other potential immune-related effects.
Apollo Hospitals provides dedicated Immunotherapy services with an emphasis on evidence-based cancer treatment, individualized therapy selection, and ongoing safety assessment. Established in 1988, the JCI accredited hospital is based in Hyderabad, India and has 550 beds supported by modern medical oncology facilities.
Immunotherapy can be used to support the body's natural immune response against certain cancers. Before starting therapy, specialists may review pathology reports, imaging results, biomarkers, previous treatments, and the patient's general health. Depending on the clinical situation, immunotherapy may be administered intravenously or through other approved routes and may be given for a defined number of cycles or until disease progression or unacceptable toxicity occurs. Follow-up assessments help determine treatment response and manage potential side effects.
Choosing Star Hospitals for Immunotherapy gives patients access to specialist-led cancer treatment, advanced diagnostic services, and coordinated follow-up care. Established in 2008, the NABH, NABL accredited hospital is located in Hyderabad, India and operates 435 beds with modern oncology infrastructure.
Immunotherapy works differently from conventional treatments that directly destroy rapidly dividing cancer cells. It helps the immune system identify, recognize, or respond more effectively to cancer cells. The treatment approach varies according to the patient's cancer and may involve checkpoint inhibitors, antibody-based medicines, or other immunotherapeutic agents. Doctors monitor patients throughout treatment to evaluate effectiveness and identify adverse reactions early.
Choosing Sterling Wockhardt Hospital for Immunotherapy gives patients access to specialist-led cancer treatment, advanced diagnostic services, and coordinated follow-up care. Established in 2001, the NABL accredited hospital is located in Mumbai, India and operates 225 beds with modern oncology infrastructure.
Immunotherapy works differently from conventional treatments that directly destroy rapidly dividing cancer cells. It helps the immune system identify, recognize, or respond more effectively to cancer cells. The treatment approach varies according to the patient's cancer and may involve checkpoint inhibitors, antibody-based medicines, or other immunotherapeutic agents. Doctors monitor patients throughout treatment to evaluate effectiveness and identify adverse reactions early.
Choosing nanavati Super Speciality Hospital for Immunotherapy gives patients access to specialist-led cancer treatment, advanced diagnostic services, and coordinated follow-up care. Established in 1950, the NABH accredited hospital is located in Mumbai, India and operates 350 beds with modern oncology infrastructure.
Immunotherapy works differently from conventional treatments that directly destroy rapidly dividing cancer cells. It helps the immune system identify, recognize, or respond more effectively to cancer cells. The treatment approach varies according to the patient's cancer and may involve checkpoint inhibitors, antibody-based medicines, or other immunotherapeutic agents. Doctors monitor patients throughout treatment to evaluate effectiveness and identify adverse reactions early.
Delhi, India
Max Super Speciality Hospital, Patparganj provides specialized Immunotherapy with a focus on personalized cancer care, appropriate treatment selection, and close monitoring during therapy. Established in 2005, the NABH, NABL, AACI accredited hospital is located in Delhi, India and operates 400 beds with advanced oncology and infusion-care facilities.
Immunotherapy uses medicines that help the body's immune system recognize and attack cancer cells more effectively. Depending on the cancer type and its characteristics, treatment may include immune checkpoint inhibitors, monoclonal antibodies, or other immune-based therapies. Before treatment, doctors may evaluate the cancer type, stage, biomarkers, and overall health to determine whether immunotherapy is appropriate. Patients are monitored regularly for treatment response and possible immune-related side effects.
Venkateshwar Hospital provides specialized Immunotherapy with a focus on personalized cancer care, appropriate treatment selection, and close monitoring during therapy. Established in 2016, the NABL, NABH accredited hospital is located in Delhi, India and operates 325 beds with advanced oncology and infusion-care facilities.
Immunotherapy uses medicines that help the body's immune system recognize and attack cancer cells more effectively. Depending on the cancer type and its characteristics, treatment may include immune checkpoint inhibitors, monoclonal antibodies, or other immune-based therapies. Before treatment, doctors may evaluate the cancer type, stage, biomarkers, and overall health to determine whether immunotherapy is appropriate. Patients are monitored regularly for treatment response and possible immune-related side effects.
Primus Super Speciality Hospital provides dedicated Immunotherapy services with an emphasis on evidence-based cancer treatment, individualized therapy selection, and ongoing safety assessment. Established in 2001, the NABH accredited hospital is based in Delhi, India and has 250 beds supported by modern medical oncology facilities.
Immunotherapy can be used to support the body's natural immune response against certain cancers. Before starting therapy, specialists may review pathology reports, imaging results, biomarkers, previous treatments, and the patient's general health. Depending on the clinical situation, immunotherapy may be administered intravenously or through other approved routes and may be given for a defined number of cycles or until disease progression or unacceptable toxicity occurs. Follow-up assessments help determine treatment response and manage potential side effects.
Millennium Cancer Center offers specialized Immunotherapy supported by experienced oncology specialists, advanced treatment technology, and structured patient monitoring. Established in 2004, the accredited hospital is situated in Gurgaon, India and has 100 beds with comprehensive cancer treatment infrastructure.
Immunotherapy may be recommended for selected patients when the cancer has specific characteristics that make it responsive to immune-based treatment. Certain medicines work by removing inhibitory signals that prevent immune cells from attacking cancer, while others target specific immune pathways or cancer-associated proteins. Treatment is usually administered according to a planned schedule, with patients monitored for fatigue, skin reactions, inflammation, and other potential immune-related effects.
We at MediGence are honoured to have been part of Krispin's journey. His resilience reminds us that healthcare is not just about medicine, but also…
| Speciality | Oncology |
| Procedure | Immunotherapy |
| Success Rate | Varies as per stage, grade and type of cancer |
| Recovery Time | Few weeks to several months |
| Treatment Time | Up to 2 Years in some cases |
| Chances of Recurrence | Varies as per stage, grade, type and location of cancer |
The top hospitals in India are well-equipped with the latest immunotherapy technologies. They have the best devices for targeted therapy, high-precision radiation equipment, robotic surgery, biomarker testing, and CAR-T cell therapy.
The top hospitals that provide Immunotherapy in India have the following features:
According to research, the success rate of immunotherapy in India ranges from about 20% to 40%. The success rate varies according to the patient's health status and the type and stage of the cancer.
You can explore the list of trustworthy, accredited hospitals in India that provide immunotherapy on the MediGence platform. It also shows the profiles of oncologists by their experience, success rates, and reviews to help you find the best ones to connect with. This results in a seamless and informed journey to find the most personalised medical solutions for cancer treatment.
Few hospitals in India offer Immunotherapy:
The cost of Immunotherapy in India typically ranges from (USD 3000 - 5000), depending on the hospital, location, and the complexity of the procedure.
Many hospitals in India offering immunotherapy specialise in treating international patients. They arrange travel and accommodation and plan treatment. Even Top-Notch Hospitals like Apollo, Fortis, and Medanta provide excellent treatment and care for their global patients.
There are some of the risks associated with Immunotherapy such as:
Recovery time after immunotherapy depends on the type of cancer and the patient's condition. Generally, patients may suffer some side effects for a few days to weeks, but recovery can take several weeks to months. Patients need regular follow-up and monitoring with their oncologist to better manage side effects.
You can consult with an oncologist before travelling to India for Immunotherapy through the MediGence platform. MediGence offers tele consultations with top oncologists, allowing you to discuss your medical condition, treatment options, and expert advice.
Post-operative treatment in India after immunotherapy generally includes monitoring for adverse effects, such as gastrointestinal problems, skin rashes, or exhaustion. Patients are given supportive care to control symptoms and regularly monitored for immune-related responses. Oncologists may suggest lifestyle changes, nutritional support, and follow-up therapy to promote recovery and enhance treatment efficacy.
India is one of the most sought-after destinations for Immunotherapy due to its advanced healthcare facilities, well-qualified doctors, and cost-effective treatment. The country has world-class medical technology and internationally accredited hospitals. MediGence ensures a hassle-free experience with personalised assistance from selecting the hospital, travel, and post-treatment care.
MediGence will contact you to arrange an appointment for Immunotherapy in India. Our case manager will connect you with the top hospitals, schedule consultations with the specialists, and guide you throughout the process, including travel and treatment planning.
In India, the time spent on immunotherapy depends on the type of cancer stage and the patient's health. Generally, it may take 4- 5 weeks with follow-up visits. Your doctor may suggest personalised treatment.
Treatment can be expected in immunotherapy to boost your immune system to attack cancer cells. The therapy could be administered as infusions, injections, or oral medications. Side effects like fatigue or skin reactions may appear, but these are usually well-tolerated. Monitoring is done regularly to ensure that the treatment is safe and effective.
Yes. In addition to immunotherapy, there are some alternative treatments, such as chemotherapy, radiation therapy, targeted therapy, and hormone therapy, available in India.
MediGence will assist you in preparing for Immunotherapy in India by providing end-to-end assistance for a hassle-free experience. We connect you with the best hospitals and experienced oncologists for an initial consultation, make necessary diagnostic tests, and provide a treatment plan tailored to your needs.
Our Case Manager will help you coordinate travel, visas, and accommodation and provide personalised support during your stay. MediGence offers the best and safest care in state-of-the-art medical facilities.
